萨库比特里尔/瓦尔萨坦改善了透析患者的心脏功能
Zaher Armaly1, Amer Saffouri2, Habib Kordahji3
1Nephrology, Edinburgh Medical Missionary Society (EMMS) Nazareth Hospital, Nazareth, ISR.
Cureus
|July 29, 2024
概括
在心力衰竭透析患者中,萨库比特里尔/瓦尔沙坦改善了心脏功能和生活质量. 这项研究表明,该药物在这个人群中对心血管健康是安全和有益的.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心力衰竭 (HF) 是慢性病 (CKD) 患者的严重并发症,尤其是透析患者.
- 透析患者面临心脏骤停的风险显著增加,这强调了改善心血管治疗的必要性.
- 萨库比特里尔/瓦尔萨坦 (Sac/Val) 显示出心脏保护作用,但由于安全问题,未经批准用于晚期CKD或透析患者.
研究的目的:
- 调查萨库比特里尔/瓦尔沙坦 (Sac/Val) 对血液透析 (HD) 患者的心力衰竭与减少喷射率 (HFrEF) 的心脏作用和安全性.
主要方法:
- 一项为期六个月的研究,涉及12名患有HFrEF的HD患者.
- 在每天100-400毫克的剂量中使用Sac/Val.
- 评估心脏功能使用心声回声学 (ECHO) 和生活质量通过堪萨斯城KCCQ-12问卷.
主要成果:
- Sac/Val治疗逐渐改善了喷射分数 (EF),而心脏几何或血液动力学没有显著变化.
- 患者报告生活质量显著改善.
- 在研究期间没有观察到任何重大不良事件,这表明安全性良好.
结论:
- 萨库比特里尔/瓦尔萨坦 (Sac/Val) 在血液透析 (HD) 和腹腔透析 (PD) 患者中显示出作为心脏保护剂的潜力.
- 这些发现支持Sac/Val在改善HFrEF透析患者心脏功能和生活质量的安全性和有效性.
- 需要进一步的综合性研究和更长的随访时间来巩固这些令人鼓舞的结果.
更多相关视频
07:24Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
24.2K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:22Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
674
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
674
01:27Dialysis
286
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
286
01:25Antihypertensive Drugs: Direct Renin Inhibitors
521
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
521
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
578
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
578